Research interests are wide-ranging, including methods for economic evaluation within clinical trials, economic models, trial design, systematic review, and meta-analysis.
Dr Seyran Naghdi is a Research Fellow in Health Economics at Warwick Medical School (WMS). She joined the University of Warwick in 2021, working primarily for the Warwick Clinical Trials Unit as a mixed method researcher to deliver a network meta-analysis on pharmacological treatment for people with chronic migraine and also a qualitative work of participants' experiences for the ARTISAN (Acute rehabilitation following traumatic anterior shoulder dislocation) trial. Before joining Warwick, she previously worked at the Iran Ministry of Health and the Iran University of Medical Sciences. She has an MSc in Health Economics from the Tehran University of Medical Sciences and a PhD in Health Policy from Iran University of Medical Sciences. She lectures on postgraduate modules and supervises undergraduate students at WMS. She is a member of the Health Economics Study Group (HESG).
- Naghdi, Seyran, Underwood, Martin, Brown, Anna, Matharu, Manjit, Duncan, Callum, Davies, Natasha, Aksentyte, Aiva, Mistry, Hema, 2024. Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults : a systematic review. BMJ Neurology Open, 6 (1)
- Rees, Sophie, Cooklin, Andrew, Duncan, Callum, Matharu, Manjit, Naghdi, Seyran, Underwood, Martin, Mistry, Hema, 2024. Research priorities for randomised controlled trials in chronic migraine preventive medication : a stakeholder consensus workshop [version 1; peer review: awaiting peer review]. NIHR open research, 4
- Naghdi, Seyran, Underwood, Martin, Madan, Jason, Brown, Anna, Duncan, Callum, Matharu, Manjit, Aksentyte, Aiva, Davies, Natasha, Rees, Sophie, Cooklin, Andrew, Grove, Amy L., Mistry, Hema, 2023. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults : a systematic review and network meta-analysis. The Journal of Headache and Pain, 24 (1)
- Mistry, Hema, Naghdi, Seyran, Underwood, Martin, Duncan, Callum, Madan, Jason, Matharu, Manjit, 2023. Competing treatments for migraine : a headache for decision-makers. The Journal of Headache and Pain, 24 (1)
- 'Khanal, Saval, 'Underwood, Martin, 'Naghdi, Seyran, 'Brown, Anna, 'Duncan, Callum, 'Matharu, Manjit, 'Mistry, Hema, 2022. 'A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine. The Journal of Headache and Pain, 23 (1)
- Ghiasvand, Hesam, Barnish, Maxwell S., Moradi, Tayebeh, Nikram, Elham, Naghdi, Seyran, 2022. Making orphan drugs and services available and accessible for people who live with rare diseases : what has been done? A systematic scoping review. Expert Opinion on Orphan Drugs, 10 (1), pp. 55-64